Pricing

Log inSign up

Cour Pharmaceuticals Development

0 followers
‌

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Industries

Biotechnology, Pharmaceutical

Headquarters

Elmhurst, United States

Employees

11-50

Links

Org chart

John J. Puisis
Co-Founder & President & CEO
Collapse
Brian C. Bock
CFO
Sarah Longoria
Chief People Officer
Robert Hodge
VP of Technical Development
SR
Stan Russell
Vice President Of Quality
DP
Darshil P.
Director of Preclinical R&D
Lori Jester
Vice President Of Manufacturing And Supply Chain

Board & advisors

Kari Nadeau
Advisor
Ciarán P. Kelly
Advisor
John Fung
Advisor
M. Eric Gershwin
Advisor
Stephen D. Miller
Advisor
Lonnie D. Shea
Advisor

Similar companies

Amgen

304 followers

Tango Therapeutics

3 followers

Arthritis Knee Pain Centers

2 followers

AbbVie

302 followers

Cellares

5 followers

Elanco

28 followers

AtriCure

4 followers

Abbott

406 followers

Bristol-Myers Squibb

277 followers

Gilead Sciences

175 followers

Regeneron

144 followers

Explore companies